Sunitinib malate 37.5 MG cap 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F21GK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,689
Award facts
- Contract value 100% obligated
- $9,688.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) valued at $9,688.95. This is a firm fixed-price delivery order with an ultimate completion date of January 27, 2026, and will be performed at the company's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. Sunitinib Malate is a tyrosine kinase inhibitor used primarily in oncology treatment, supporting the Defense Logistics Agency's pharmaceutical supply requirements for military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This parent indefinite delivery vehicle enables AmerisourceBergen, a subsidiary of parent company Cencora, Inc., to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The indefinite delivery contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F21GK?
SPE2DR26F21GK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F21GK worth?
The government has obligated $9,689 on SPE2DR26F21GK.
Is contract SPE2DR26F21GK an order under another contract?
Yes. SPE2DR26F21GK is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21GK competed?
The extent of competition for SPE2DR26F21GK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award